Menopause Treatment Market 2019 – Size Expansion, Key Development, Share, Growth Insights, Regional Demand and Foreseen by 2023
Jun 12, 2019
Menopause Treatment Market Information: By Hormonal Treatment (Estrogen, Progesterone, Combination), Non-Hormonal Treatment (Anti-Depressants, Anti-Anxiety, Anti-Migraine), End-User (Hospitals & Clinics, Academia & Research) - Global Forecast Till 2023
pune, India - June 12, 2019 /MarketersMedia/ —
All most 85% of women experience menopause at the age of 40, which is normal. However, various complications may arise for post postmenopausal women. Such incidences have increased in recent years, and thereby fuelling the demand for menopause treatment. According to the latest report published Market Research Future (MRFR), the global menopause treatment market is set to surge at 4.2% CAGR between 2017 and 2023. Towards the end of the forecast period, the market is expected to surpass a valuation of USD 3 bn.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4579
Reduction in estrogen production and increase secretion of gonadotropin is a common health issue in women post menopause. This could create cessation or irregularities in menstrual flow and cycle, which may lead to vasomotor symptoms. Among symptoms, hot flash is most common. Apart from hot flash, patient may also experience itchiness, abnormal skin sensation, and burning or tingling on the skin.
There are several types of treatments available for menopause related disorders. The growth of the menopause market can be attributed to various factors, which include rising level of awareness about women health, growing number of healthcare and gynaecology centres and advances in hormonal drugs.
Segmental Overview
MRFR’s report includes a thorough segmental analysis of the global Menopause Treatment Market based on non-hormonal treatment, hormonal treatment and end user.
By non-hormonal treatment, the market has been segmented into anti-anxiety, anti-depressants, migraine and others. By hormonal treatment, the market has been segmented into progesterone, estrogen, combination of the two (estrogen and progesterone) and others. By end user, the market has been segmented into academic and research, hospitals & clinics and others.
Enquire About Report @ https://www.marketresearchfuture.com/enquiry/4579
Global Menopause Treatment Market: Regional Segmentation
Regions covered in MRFR’s report include North America, Europe, Latin America, Asia Pacific (APAC) and the Middle East & Africa (MEA). Of these, North America and Latin America collectively account for the standout share of the global Menopause Treatment Market. This is mainly owing to the high healthcare expenditure. Health expenditure in the U.S. accounts for nearly 16% of GDP. Several macro and microeconomic factors can be linked with the incessant growth of the pharmaceutical industry in the region. Moreover, faster penetration of new drugs in countries such as the U.S., Canada, Mexico supports the market growth in North America. The region is home to a large number of pharmaceutical companies, which gives the domestic market an advantage.
Europe follows North America in the pecking order, representing the second largest market for menopause treatment. Presence of world class healthcare infrastructure coupled with favourable reimbursement policies is partly propelling the market in Europe. During the forecast period, the U.K., Germany, and France are expected to make significant contribution the market in terms of revenue.
The menopause treatment market is expected to witness an impressive growth in APAC. China and India are expected two most important investment destination for market players operating APAC. These two countries are undergoing transformation in massive scale in various verticals including healthcare.
Competitive Landscape
Some of the leading market participants discussed in MRFR report include Novartis AG, Pfizer, Inc., Emcure Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Novo Nordisk A/S, Eli Lilly and Company, Allergan plc, and Cipla Inc.
Industry News
The USFDA has recently approved a new drug Evenity (romosozumab-aqqg) for treating osteoporosis in women with high risk of bone fracture post menopause. The drug can be used in women with medical history of osteoporotic fracture or risks associated with fracture. The drug is touted as a prudent alternative to other non-effective osteoporosis treatment.
Duchesnay, a prominent pharmaceutical company having expertise in women health recently received FDA approval for a supplemental New Drug Application (sNDA) for Osphena (ospemifene). sNDA can be used for treating moderate to severe vaginal dryness.
Read Complete Report With Toc@ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: WantStats Research and Media Pvt. Ltd. Office No. 528, Amanora Chambers
Phone: 6468459312
Website: https://www.marketresearchfuture.com/
Source: MarketersMedia
Release ID: 523461
More News
Indonesia’s commodity export U-turn: no monopoly, just all the data
Indonesia has abandoned plans to make a powerful new state-owned enterprise the “sole exporter” of its palm oil, coal and ferroalloys, in a move that has reassured some businesses, even as questions over oversight and pricing remain. President Prabowo Subianto’s original proposal to tighten the government’s control over the three major commodities, put forward in May, had prompted speculation that state-linked companies could gain an unfair advantage through access to commercially sensitive data...
Trump to Meet With Putin and Xi in China, With Nuclear Proliferation on the Agenda
The president plans to also discuss the war against Iran, but is not expected to bring up Russia’s war in Ukraine or the scandal that has engulfed Jensen Huang.
Melaka election: Malaysians vote as Anwar’s PH seeks to stem Umno tide
Voters are casting their ballots on Saturday to decide who will govern the southern Malaysian state of Melaka amid concerns over turnout due to rain forecasts, with the odds stacked against Prime Minister Anwar Ibrahim’s ruling Pakatan Harapan (PH) coalition against the incumbent Umno. By around 11.30am, nearly 35 per cent of the 669,211 eligible voters had cast their ballots according to the Election Commission’s online dashboard. The polls mark the third state electoral battle between PH and...
Pax Silica means peace. In the Philippines, it’s a fight
Outside the Grand Hyatt hotel in Manila earlier this year, five people were arrested as hundreds of activists chanting “Junk Pax Silica!” clashed with anti-riot police. Inside, Philippine President Ferdinand Marcos Jnr hobnobbed with some 600 investors, industry leaders and officials at a US-sponsored forum, urging them to sink their money into the US-led scheme. The Philippines is planning to build a sprawling 1,620-hectare (4,000-acre) “Pax Silica” technology hub near a former American...
Nvidia Scandal Unleashes a Flood of AI-Generated Memes
The revelations surrounding Jensen Huang, who resigned from Nvidia over extramarital affairs, inspired social media posts using the very technology his company helped develop.
Trump and Xi Can Reopen Trade. But for Whom?
The narrative of easing trade tensions doesn’t tell us who reaps the benefits of these developments at the company level.
Will AI Change North Korea’s Nuclear Calculus?
Nuclear stability requires mutual vulnerability. Artificial general intelligence could upset asymmetric deterrence equilibria, especially vis-à-vis Pyongyang.
North Korea’s Last Defectors
Fewer people are making it out of North Korea. That allows Kim Jong Un to exert more control over his country’s image abroad.
Jensen Huang’s Fall Costs Asia an A.I. Ambassador to the U.S.
The ex-Nvidia C.E.O. was a bridge between companies and governments. His exit will reverberate, especially in China where it could accelerate a self-reliance drive.
South Korea’s Options in a Fragmented World
Seoul would be an attractive addition to several different international groupings – but joining one could mean locking South Korea out of others.
Japan Needs Muslim Workers. Is It Ready for Muslim Communities?
Tensions will flare up when cherished social institutions need to change to accommodate nonnegotiable religious needs. But they must start, even if it is only with a hijab or a burial.
NATO Is Not the Right Forum to Discuss China
No matter how strange and exaggerated NATO finds the Chinese perspective on the alliance, the organization should consider addressing Beijing’s concerns.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.